Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

2.

Use of physical restraints and antipsychotic medications in nursing homes: a cross-national study.

Feng Z, Hirdes JP, Smith TF, Finne-Soveri H, Chi I, Du Pasquier JN, Gilgen R, Ikegami N, Mor V.

Int J Geriatr Psychiatry. 2009 Oct;24(10):1110-8. doi: 10.1002/gps.2232.

3.

Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.

Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA.

BMJ. 2004 Jul 10;329(7457):75. Epub 2004 Jun 11. Review.

5.

The effectiveness of quality systems in nursing homes: a review.

Wagner C, van der Wal G, Groenewegen PP, de Bakker DH.

Qual Health Care. 2001 Dec;10(4):211-7. Review.

6.

Use of physical restraints and psychotropic medications in Alzheimer special care units in nursing homes.

Phillips CD, Spry KM, Sloane PD, Hawes C.

Am J Public Health. 2000 Jan;90(1):92-6.

7.

Impact of legislation on nursing home care in the United States: lessons for the United Kingdom.

Hughes CM, Lapane KL, Mor V.

BMJ. 1999 Oct 16;319(7216):1060-2. No abstract available.

8.

Neuroleptic prescribing in residents of nursing homes. Access to psychiatrists should be improved.

Tarbuck AF.

BMJ. 1996 Jun 29;312(7047):1667-8; author reply 1669. No abstract available.

9.

Neuroleptic prescribing in residents of nursing homes. Geographical differences make extrapolation difficult.

Passmore AP, Crawford VL, Beringer TR, Fullerton KJ, McCaffrey PM.

BMJ. 1996 Jun 29;312(7047):1667. No abstract available.

10.

Survey of neuroleptic prescribing in residents of nursing homes in Glasgow.

McGrath AM, Jackson GA.

BMJ. 1996 Mar 9;312(7031):611-2. No abstract available.

Supplemental Content

Support Center